Literature DB >> 29742231

Duration of effectiveness of Botulinum toxin type A in excessive gingival display: a systematic review and meta-analysis.

Taísa Figueiredo Chagas1, Natalia Valli de Almeida1, Cinthia Oliveira Lisboa1, Daniele Masterson Tavares Pereira Ferreira2, Claudia Trindade Mattos1, José Nelson Mucha1.   

Abstract

Botulinum toxin type A is effective in reducing excessive gingival display caused by hyperfunctional upper lip elevator muscles; however, this effect is transient. This study aimed to determine the duration of the effectiveness of botulinum toxin type A on a gummy smile. A systematic search was conducted using Medline (PubMed), Scopus, and Web of Science electronic databases, from 1970 to March 2017 with no language restriction; the search included studies evaluating adult patients with excessive gingival display who were treated with botulinum toxin and were followed-up for at least 3 months. OpenGrey and Clinical Trial Registry were also consulted. Quality assessment was applied to determine the level of evidence and bias, and a meta-analysis was performed. Of 2181 full texts, 71 were obtained, with 3 prospective studies meeting the selection criteria. The gingival display was significantly reduced to baseline with 2, 4, and 8 weeks of treatment. The gingival display considerably reduced at the baseline-2-week comparison (-4.44 mm using raw data and-4.05 mm using the standard difference) and increased throughout the weeks of follow-up. There is scant evidence to determine the duration of the effectiveness of toxin type A on a gummy smile. The effect tends to be stable until at least 8 weeks of follow-up, and the gingival exposure may not return to baseline within 12 weeks of follow-up. Well-designed randomized clinical trials with a minimum of 6 months of follow-up are necessary to strengthen the evidence.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29742231     DOI: 10.1590/1807-3107bor-2018.vol32.0030

Source DB:  PubMed          Journal:  Braz Oral Res        ISSN: 1806-8324


  3 in total

1.  Effects of different doses of abobotulinumtoxinA for the treatment of anterior gingival smile.

Authors:  Doris Hexsel; Taciana Dal'Forno; Fernanda Camozzato; Indira Valente; Mariana Soirefmann; Aline Flor Silva; Carolina Siega
Journal:  Arch Dermatol Res       Date:  2020-07-28       Impact factor: 3.017

2.  EUS-Guided Intragastric Injection of Botulinum Toxin A in the Preoperative Treatment of Super-Obese Patients: a Randomized Clinical Trial.

Authors:  Eduardo Guimarães Hourneaux de Moura; Igor Braga Ribeiro; Mariana Souza Varela Frazão; Luiz Henrique Mazzonetto Mestieri; Diogo Turiani Hourneaux de Moura; Creusa Maria Roveri Dal Bó; Vitor Ottoboni Brunaldi; Eduardo Turiani Hourneaux de Moura; Gabriel Cairo Nunes; Fábio Alberto Castillo Bustamante; Manoel Dos Passos Galvão Neto; Sergio Eiji Matuguma; Wanderley Marques Bernardo; Marco Aurélio Santo
Journal:  Obes Surg       Date:  2019-01       Impact factor: 4.129

Review 3.  Effect and longevity of botulinum toxin in the treatment of gummy smile: a meta-analysis and meta-regression.

Authors:  Aline Cristina Soares Zengiski; Isabela Bittencourt Basso; Bianca L Cavalcante-Leão; José Stechman-Neto; Rosane Sampaio Santos; Odilon Guariza-Filho; Bianca Simone Zeigelboim; Karinna Veríssimo Meira Taveira; Cristiano Miranda de Araujo
Journal:  Clin Oral Investig       Date:  2021-10-15       Impact factor: 3.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.